Navigator Support for Colorectal Cancer

This trial tests a new support program for Latinx individuals recently diagnosed with colorectal cancer. The researchers aim to determine if a community health worker (CHW) or patient navigator can enhance the healthcare experience by providing support such as attending medical visits, arranging transportation, and connecting participants to social services. Participants will be randomly assigned to either a group receiving this additional support or a group receiving a list of social services. Ideal candidates are those diagnosed with colon or rectal cancer in the last 30 days who plan to receive treatment in Santa Clara County. As an unphased trial, this study offers a unique opportunity to improve healthcare experiences through personalized support.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that using Community Health Workers (CHWs) and Patient Navigators is both safe and beneficial. Studies have found that these programs expedite and enhance cancer screenings, such as for colorectal cancer. This indicates successful past use without safety issues.

Researchers are excited about Navigator Support for Colorectal Cancer because it offers a personalized, hands-on approach that’s different from standard care. While usual care might involve receiving a list of social services, this method assigns a Community Health Worker/Patient Navigator to each participant. These navigators don’t just explain treatment plans but also help with scheduling, transportation, and connecting patients with social support services, maintaining regular contact for up to six months. This approach aims to address both medical and social needs, potentially improving patient experiences and outcomes in ways that traditional treatments alone might not achieve.

Research has shown that programs with community health workers (CHWs) and patient navigators help more people complete cancer screenings, such as those for colorectal cancer, on time. In this trial, participants in the intervention group will receive support from a CHW or patient navigator. One study found that these programs improve cancer care by connecting patients with necessary resources and support. They also prove cost-effective, especially for individuals with low incomes or no insurance, by making cancer screenings more accessible. By reducing health disparities among groups, CHW programs can enhance health outcomes for colorectal cancer patients. This support can lead to better disease management and may improve quality of life.¹²⁴⁶⁷